1. Home
  2. RFL

as 11-15-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Finance

Real Estate

Nasdaq

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.

Founded: 2017 Country:
United States
United States
Employees: N/A City: NEWARK
Market Cap: 48.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 26.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.45 EPS Growth: N/A
52 Week Low/High: $1.29 - $2.50 Next Earning Date: 12-12-2024
Revenue: $637,000 Revenue Growth: 128.32%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

RFL Daily Stock ML Predictions

Share on Social Networks: